selective estrogen receptor modulator

tamoxifen 
raloxifene 

moa 
competitive inhibitor of estrogen binding
mixed agonist/antagonist action 

indications 
prevention of breast cancer in high-risk patients 
tamoxifen" adjuvant treatment of breast cancer 
raloxifene: postmenopausal osteoporosis 

adverse effects 
hot flashes 
venous thromboembolism 
endometrial hyperplasia and carcinoma (tamoxifen)
uterine sarcoma (tamoxifen)

QID 2606